PATENT CLAIM ANALYSIS

Application Number: 15746806
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["514", "04400A"]

Abstract:
The present invention relates to the combination of a PARP inhibitor with a Dbait molecule for treating cancer.

Claim (Index 7):
The pharmaceutical composition according to  claim 1 , wherein the nucleic acid molecule is

Metadata:
- Claim Count in Document: 67.0
- Percentile: 86.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13703965', '14118583', '15632951', '15232844', '14923482']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.843723853318448
- 35 USC 102 Novelty (BERT): 0.5848644169027903
- Combined Prediction Score: 0.8178379096768823
- Mean Citation Score: 480.07088600000014
- Max Citation Score: 505.55835
- Similarity Product: 429.4699502812654

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test